While recurrence free survival is the accepted surrogate endpoint for oncology, biomarker-based outcomes assessment with ctDNA may offer greater precision and sensitivity. What could acceptance of biomarker-based surroga...
Search tips
- As you type, predictive text will suggest keywords with matching content on our website. You can easily select one if it matches what you are looking for.
- Our AI powered site search can provide AI generated summaries, particularly if your search query is phrased as a question
- We use semantic technology (NLP) to broaden search queries with synonyms e.g. 'cancer' = 'oncology'
- Use quotation marks " " to search for an exact phrase.
- Our site search will accommodate variations between Irish/British and American English spelling.
- Use the filters to narrow your search results. Select just one or several.
- 'Date' = date page last updated
- Boolean must be typed in all-caps e.g.:
- AND - include both terms (i.e. narrower search)
- NOT - exclude a term (specific context of search)
- OR - include either term (i.e. broader search)